Click for best price
Poliomyelitis Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 730.3 million
|
Forecast Market size by 2029 |
US$ 850.6 million
|
| Growth Rate |
CAGR of 2.2% |
Number of Pages |
79 Pages |
The global Poliomyelitis Vaccines market was valued at US$ 730.3 million in 2022 and is projected to reach US$ 850.6 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.
This report aims to provide a comprehensive presentation of the global market for Poliomyelitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomyelitis Vaccines. This report contains market size and forecasts of Poliomyelitis Vaccines in global, including the following market information:
- Global Poliomyelitis Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Poliomyelitis Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
- Global top five Poliomyelitis Vaccines companies in 2022 (%)
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 99% market shares.
We surveyed the Poliomyelitis Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poliomyelitis Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, by Type, 2022 (%)
Global Poliomyelitis Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, by Application, 2022 (%)
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
Global Poliomyelitis Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Poliomyelitis Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poliomyelitis Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poliomyelitis Vaccines revenues share in global market, 2022 (%)
Key companies Poliomyelitis Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Poliomyelitis Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Poliomyelitis Vaccines, market overview.
- Chapter 2: Global Poliomyelitis Vaccines market size in revenue and volume.
- Chapter 3: Detailed analysis of Poliomyelitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Poliomyelitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Poliomyelitis Vaccines capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Poliomyelitis Vaccines Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 730.3 million
|
| Forecast Market size by 2029 |
US$ 850.6 million
|
| Growth Rate |
CAGR of 2.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Poliomyelitis Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Poliomyelitis Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Poliomyelitis Vaccines Overall Market Size
2.1 Global Poliomyelitis Vaccines Market Size: 2022 VS 2032
2.2 Global Poliomyelitis Vaccines Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Poliomyelitis Vaccines Sales: 2018-2032
3 Company Landscape
3.1 Top Poliomyelitis Vaccines Players in Global Market
3.2 Top Global Poliomyelitis Vaccines Companies Ranked by Revenue
3.3 Global Poliomyelitis Vaccines Revenue by Companies
3.4 Global Poliomyelitis Vaccines Sales by Companies
3.5 Global Poliomyelitis Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Poliomyelitis Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Poliomyelitis Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Poliomyelitis Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Poliomyelitis Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Poliomyelitis Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Poliomyelitis Vaccines Market Size Markets, 2022 & 2032
4.1.2 IPV
4.1.3 OPV
4.2 By Type - Global Poliomyelitis Vaccines Revenue & Forecasts
4.2.1 By Type - Global Poliomyelitis Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Poliomyelitis Vaccines Revenue, 2024-2032
4.2.3 By Type - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
4.3 By Type - Global Poliomyelitis Vaccines Sales & Forecasts
4.3.1 By Type - Global Poliomyelitis Vaccines Sales, 2018-2023
4.3.2 By Type - Global Poliomyelitis Vaccines Sales, 2024-2032
4.3.3 By Type - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
4.4 By Type - Global Poliomyelitis Vaccines Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Poliomyelitis Vaccines Market Size, 2022 & 2032
5.1.2 Research & Academic Laboratories
5.1.3 Pharmaceutical & Biotechnology Companies
5.1.4 Others
5.2 By Application - Global Poliomyelitis Vaccines Revenue & Forecasts
5.2.1 By Application - Global Poliomyelitis Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Poliomyelitis Vaccines Revenue, 2024-2032
5.2.3 By Application - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
5.3 By Application - Global Poliomyelitis Vaccines Sales & Forecasts
5.3.1 By Application - Global Poliomyelitis Vaccines Sales, 2018-2023
5.3.2 By Application - Global Poliomyelitis Vaccines Sales, 2024-2032
5.3.3 By Application - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
5.4 By Application - Global Poliomyelitis Vaccines Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Poliomyelitis Vaccines Market Size, 2022 & 2032
6.2 By Region - Global Poliomyelitis Vaccines Revenue & Forecasts
6.2.1 By Region - Global Poliomyelitis Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Poliomyelitis Vaccines Revenue, 2024-2032
6.2.3 By Region - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
6.3 By Region - Global Poliomyelitis Vaccines Sales & Forecasts
6.3.1 By Region - Global Poliomyelitis Vaccines Sales, 2018-2023
6.3.2 By Region - Global Poliomyelitis Vaccines Sales, 2024-2032
6.3.3 By Region - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Poliomyelitis Vaccines Revenue, 2018-2032
6.4.2 By Country - North America Poliomyelitis Vaccines Sales, 2018-2032
6.4.3 US Poliomyelitis Vaccines Market Size, 2018-2032
6.4.4 Canada Poliomyelitis Vaccines Market Size, 2018-2032
6.4.5 Mexico Poliomyelitis Vaccines Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Poliomyelitis Vaccines Revenue, 2018-2032
6.5.2 By Country - Europe Poliomyelitis Vaccines Sales, 2018-2032
6.5.3 Germany Poliomyelitis Vaccines Market Size, 2018-2032
6.5.4 France Poliomyelitis Vaccines Market Size, 2018-2032
6.5.5 U.K. Poliomyelitis Vaccines Market Size, 2018-2032
6.5.6 Italy Poliomyelitis Vaccines Market Size, 2018-2032
6.5.7 Russia Poliomyelitis Vaccines Market Size, 2018-2032
6.5.8 Nordic Countries Poliomyelitis Vaccines Market Size, 2018-2032
6.5.9 Benelux Poliomyelitis Vaccines Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Poliomyelitis Vaccines Revenue, 2018-2032
6.6.2 By Region - Asia Poliomyelitis Vaccines Sales, 2018-2032
6.6.3 China Poliomyelitis Vaccines Market Size, 2018-2032
6.6.4 Japan Poliomyelitis Vaccines Market Size, 2018-2032
6.6.5 South Korea Poliomyelitis Vaccines Market Size, 2018-2032
6.6.6 Southeast Asia Poliomyelitis Vaccines Market Size, 2018-2032
6.6.7 India Poliomyelitis Vaccines Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Poliomyelitis Vaccines Revenue, 2018-2032
6.7.2 By Country - South America Poliomyelitis Vaccines Sales, 2018-2032
6.7.3 Brazil Poliomyelitis Vaccines Market Size, 2018-2032
6.7.4 Argentina Poliomyelitis Vaccines Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Poliomyelitis Vaccines Sales, 2018-2032
6.8.3 Turkey Poliomyelitis Vaccines Market Size, 2018-2032
6.8.4 Israel Poliomyelitis Vaccines Market Size, 2018-2032
6.8.5 Saudi Arabia Poliomyelitis Vaccines Market Size, 2018-2032
6.8.6 UAE Poliomyelitis Vaccines Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Poliomyelitis Vaccines Major Product Offerings
7.1.4 Sanofi Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Poliomyelitis Vaccines Major Product Offerings
7.2.4 GSK Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Bibcol
7.3.1 Bibcol Company Summary
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Poliomyelitis Vaccines Major Product Offerings
7.3.4 Bibcol Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Bibcol Key News & Latest Developments
7.4 Serum Institute
7.4.1 Serum Institute Company Summary
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Poliomyelitis Vaccines Major Product Offerings
7.4.4 Serum Institute Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Serum Institute Key News & Latest Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Company Summary
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Poliomyelitis Vaccines Major Product Offerings
7.5.4 Tiantan Biological Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Tiantan Biological Key News & Latest Developments
7.6 IMBCA
7.6.1 IMBCA Company Summary
7.6.2 IMBCA Business Overview
7.6.3 IMBCA Poliomyelitis Vaccines Major Product Offerings
7.6.4 IMBCA Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 IMBCA Key News & Latest Developments
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Company Summary
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Major Product Offerings
7.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Panacea Biotec Ltd Key News & Latest Developments
7.8 Bio-Med
7.8.1 Bio-Med Company Summary
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Poliomyelitis Vaccines Major Product Offerings
7.8.4 Bio-Med Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Bio-Med Key News & Latest Developments
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Company Summary
7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Major Product Offerings
7.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Poliomyelitis Vaccines Production Capacity, Analysis
8.1 Global Poliomyelitis Vaccines Production Capacity, 2018-2032
8.2 Poliomyelitis Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Poliomyelitis Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Poliomyelitis Vaccines Supply Chain Analysis
10.1 Poliomyelitis Vaccines Industry Value Chain
10.2 Poliomyelitis Vaccines Upstream Market
10.3 Poliomyelitis Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Poliomyelitis Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Poliomyelitis Vaccines in Global Market
Table 2. Top Poliomyelitis Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Poliomyelitis Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Poliomyelitis Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Poliomyelitis Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Poliomyelitis Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Poliomyelitis Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Poliomyelitis Vaccines Product Type
Table 9. List of Global Tier 1 Poliomyelitis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Poliomyelitis Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Poliomyelitis Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Poliomyelitis Vaccines Sales (K Units), 2024-2032
Table 16. By Application ? Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Poliomyelitis Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Poliomyelitis Vaccines Sales (K Units), 2024-2032
Table 21. By Region ? Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Poliomyelitis Vaccines Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Poliomyelitis Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Poliomyelitis Vaccines Sales (K Units), 2024-2032
Table 26. By Country - North America Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Poliomyelitis Vaccines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Poliomyelitis Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Poliomyelitis Vaccines Sales, (K Units), 2024-2032
Table 30. By Country - Europe Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Poliomyelitis Vaccines Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Poliomyelitis Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Poliomyelitis Vaccines Sales, (K Units), 2024-2032
Table 34. By Region - Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Poliomyelitis Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Poliomyelitis Vaccines Sales, (K Units), 2024-2032
Table 38. By Country - South America Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Poliomyelitis Vaccines Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Poliomyelitis Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Poliomyelitis Vaccines Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Poliomyelitis Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Poliomyelitis Vaccines Sales, (K Units), 2024-2032
Table 46. Sanofi Company Summary
Table 47. Sanofi Poliomyelitis Vaccines Product Offerings
Table 48. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Poliomyelitis Vaccines Product Offerings
Table 52. GSK Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Bibcol Company Summary
Table 55. Bibcol Poliomyelitis Vaccines Product Offerings
Table 56. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bibcol Key News & Latest Developments
Table 58. Serum Institute Company Summary
Table 59. Serum Institute Poliomyelitis Vaccines Product Offerings
Table 60. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Serum Institute Key News & Latest Developments
Table 62. Tiantan Biological Company Summary
Table 63. Tiantan Biological Poliomyelitis Vaccines Product Offerings
Table 64. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Tiantan Biological Key News & Latest Developments
Table 66. IMBCA Company Summary
Table 67. IMBCA Poliomyelitis Vaccines Product Offerings
Table 68. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. IMBCA Key News & Latest Developments
Table 70. Panacea Biotec Ltd Company Summary
Table 71. Panacea Biotec Ltd Poliomyelitis Vaccines Product Offerings
Table 72. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Panacea Biotec Ltd Key News & Latest Developments
Table 74. Bio-Med Company Summary
Table 75. Bio-Med Poliomyelitis Vaccines Product Offerings
Table 76. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Bio-Med Key News & Latest Developments
Table 78. Halfkin Bio-Pharmaceuticals Company Summary
Table 79. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Offerings
Table 80. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 82. Poliomyelitis Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Poliomyelitis Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Poliomyelitis Vaccines Production by Region, 2018-2023 (K Units)
Table 85. Global Poliomyelitis Vaccines Production by Region, 2024-2032 (K Units)
Table 86. Poliomyelitis Vaccines Market Opportunities & Trends in Global Market
Table 87. Poliomyelitis Vaccines Market Drivers in Global Market
Table 88. Poliomyelitis Vaccines Market Restraints in Global Market
Table 89. Poliomyelitis Vaccines Raw Materials
Table 90. Poliomyelitis Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical Poliomyelitis Vaccines Downstream
Table 92. Poliomyelitis Vaccines Downstream Clients in Global Market
Table 93. Poliomyelitis Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Poliomyelitis Vaccines Segment by Type in 2022
Figure 2. Poliomyelitis Vaccines Segment by Application in 2022
Figure 3. Global Poliomyelitis Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Poliomyelitis Vaccines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Poliomyelitis Vaccines Revenue, 2018-2032 (US$, Mn)
Figure 7. Poliomyelitis Vaccines Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Poliomyelitis Vaccines Revenue in 2022
Figure 9. By Type - Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 11. By Type - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 12. By Type - Global Poliomyelitis Vaccines Price (USD/Unit), 2018-2032
Figure 13. By Application - Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 15. By Application - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 16. By Application - Global Poliomyelitis Vaccines Price (USD/Unit), 2018-2032
Figure 17. By Region - Global Poliomyelitis Vaccines Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Poliomyelitis Vaccines Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 20. By Region - Global Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 21. By Country - North America Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 22. By Country - North America Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 23. US Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 28. Germany Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 29. France Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 37. China Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 41. India Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 43. By Country - South America Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 44. Brazil Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Poliomyelitis Vaccines Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Poliomyelitis Vaccines Sales Market Share, 2018-2032
Figure 48. Turkey Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Poliomyelitis Vaccines Revenue, (US$, Mn), 2018-2032
Figure 52. Global Poliomyelitis Vaccines Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Poliomyelitis Vaccines by Region, 2022 VS 2032
Figure 54. Poliomyelitis Vaccines Industry Value Chain
Figure 55. Marketing Channels
